Skip to main content
Christina Moon, MD, Ophthalmology, Philadelphia, PA

ChristinaSoyoungMoonMD

Ophthalmology Philadelphia, PA

Anterior Segment Related, Cataract Related, Cornea & External Disease, Refractive Surgery

Physician

Dr. Moon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Moon's full profile

Already have an account?

  • Office

    51 North 39th Street
    Philadelphia, PA 19104
    Phone+1 215-662-8107
    Fax+1 215-615-0527

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Cornea, External Diseases, and Refractive Surgery, 2012 - 2013
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Ophthalmology, 2009 - 2012
  • Albert Einstein Medical Center
    Albert Einstein Medical CenterInternship, Transitional Year, 2008 - 2009
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2008

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2008 - 2026
  • FL State Medical License
    FL State Medical License 2012 - 2020
  • MA State Medical License
    MA State Medical License 2013 - 2020
  • DE State Medical License
    DE State Medical License 2017 - 2019
  • MD State Medical License
    MD State Medical License 2015 - 2019
  • NJ State Medical License
    NJ State Medical License 2017 - 2019
  • VA State Medical License
    VA State Medical License 2015 - 2018
  • American Board of Ophthalmology Ophthalmology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Immune Phenotype of Patients with Stage IV Metastatic Inflammatory Breast Cancer
    Immune Phenotype of Patients with Stage IV Metastatic Inflammatory Breast CancerDecember 2nd, 2020